| Literature DB >> 21822439 |
Ronghai He1, Haile Ma, Weirui Zhao, Wenjuan Qu, Jiewen Zhao, Lin Luo, Wenxue Zhu.
Abstract
A quantitative structure-activity relationship (QSAR) model of angiotensin-converting enzyme- (ACE-) inhibitory peptides was built with an artificial neural network (ANN) approach based on structural or activity data of 58 dipeptides (including peptide activity, hydrophilic amino acids content, three-dimensional shape, size, and electrical parameters), the overall correlation coefficient of the predicted versus actual data points is R = 0.928, and the model was applied in ACE-inhibitory peptides preparation from defatted wheat germ protein (DWGP). According to the QSAR model, the C-terminal of the peptide was found to have principal importance on ACE-inhibitory activity, that is, if the C-terminal is hydrophobic amino acid, the peptide's ACE-inhibitory activity will be high, and proteins which contain abundant hydrophobic amino acids are suitable to produce ACE-inhibitory peptides. According to the model, DWGP is a good protein material to produce ACE-inhibitory peptides because it contains 42.84% of hydrophobic amino acids, and structural information analysis from the QSAR model showed that proteases of Alcalase and Neutrase were suitable candidates for ACE-inhibitory peptides preparation from DWGP. Considering higher DH and similar ACE-inhibitory activity of hydrolysate compared with Neutrase, Alcalase was finally selected through experimental study.Entities:
Year: 2011 PMID: 21822439 PMCID: PMC3133453 DOI: 10.1155/2012/620609
Source DB: PubMed Journal: Int J Pept ISSN: 1687-9767
Z descriptor scores for amino acids.
| Amino | Code |
|
|
| Amino | Code |
| Z2 |
|
|---|---|---|---|---|---|---|---|---|---|
| acid | acid | ||||||||
| Ala | A | 0.07 | −1.73 | 0.09 | His | H | 2.41 | 1.74 | 1.11 |
| Val | V | −2.69 | −2.53 | −1.29 | Gly | G | 2.23 | −5.36 | 0.30 |
| Leu | L | −4.19 | −1.03 | −0. 98 | Ser | S | 1.96 | −1.63 | 0.57 |
| Lie | I | −4.44 | −1.68 | −1.03 | Thr | T | 0.92 | −2.09 | −1.40 |
| Pro | P | −1.22 | 0.88 | 2.23 | Cys | C | 0.71 | −0.97 | 4.13 |
| Phe | F | −4.92 | 1.30 | 0.45 | Tyr | Y | −1.39 | 2.32 | 0.01 |
| Trp | W | −4.75 | 3.65 | 0.85 | Asn | N | 3.22 | 1.45 | 0.84 |
| Met | M | −2.49 | −0.27 | −0.41 | GIn | Q | 2.18 | 0.53 | −1.14 |
| Lys | K | 2.84 | 1.41 | −3.14 | Asp | D | 3.64 | 1.13 | 2.36 |
| Arg | R | 2.88 | 2.52 | −3.44 | Glu | E | 3.08 | 0.39 | −0.07 |
The ACE-inhibitory peptides' sequences with Z descriptor activity.
| Peptide | Log(1/IC50) |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| AA | 3.21 | 0.07 | −1.73 | 0.09 | 0.07 | −1.73 | 0.09 |
| AW | 5 | 0.07 | −1.73 | 0.09 | −4.75 | 3.65 | 0.85 |
| DG | 1.85 | 3.64 | 1.13 | 2.36 | 2.23 | −5.36 | 0.3 |
| GF | 3.2 | 2.23 | −5.36 | 0.3 | −4.92 | 1.3 | 0.45 |
| GP | 3.35 | 2.23 | −5.36 | 0.3 | −1.22 | 0.88 | 2.23 |
| GR | 2.49 | 2.23 | −5.36 | 0.3 | 2.88 | 2.52 | −3.44 |
| GW | 4.52 | 2.23 | −5.36 | 0.3 | −4.75 | 3.65 | 0.85 |
| GY | 3.68 | 2.23 | −5.36 | 0.3 | −1.39 | 2.32 | 0.01 |
| IF | 3.03 | −4.44 | −1.68 | −1.03 | −4.92 | 1.3 | 0.45 |
| IW | 5.7 | −4.44 | −1.68 | −1.03 | −4.75 | 3.65 | 0.85 |
| IY | 5.43 | −4.44 | −1.68 | −1.03 | −1.39 | 2.32 | 0.01 |
| RF | 3.64 | 2.88 | 2.52 | −3.44 | −4.92 | 1.3 | 0.45 |
| RP | 1.1818 | 2.88 | 2.52 | −3.44 | −1.22 | 0.88 | 2.23 |
| VG | 2.96 | −2.69 | −2.53 | −1.29 | 2.23 | −5.36 | 0.3 |
| VW | 1.6 | −2.69 | −2.53 | −1.29 | −4.75 | 3.65 | 0.85 |
| VY | 4.66 | −2.69 | −2.53 | −1.29 | −1.39 | 2.32 | 0.01 |
| YG | 2.7 | −1.39 | 2.32 | 0.01 | 2.23 | −5.36 | 0.3 |
| RW | 4.8 | 2.88 | 2.52 | −3.44 | −4.75 | 3.65 | 0.85 |
| AY | 4.28 | −2.69 | −2.53 | −1.29 | −4.92 | 1.3 | 0.45 |
| RP | 3.89 | −4.44 | −1.68 | −1.03 | −1.22 | 0.88 | 2.23 |
| AF | 3.72 | 0.07 | −1.73 | 0.09 | −4.92 | 1.3 | 0.45 |
| AP | 3.64 | 0.07 | −1.73 | 0.09 | −1.22 | 0.88 | 2.23 |
| VP | 3.38 | −2.69 | −2.53 | −1.29 | −1.22 | 0.88 | 2.23 |
| IG | 2.92 | −4.44 | −1.68 | −1.03 | 2.23 | −5.36 | 0.3 |
| GI | 2.92 | 2.23 | −5.36 | 0.3 | −4.44 | −1.68 | −1.03 |
| GM | 2.85 | 2.23 | −5.36 | 0.3 | −2.49 | −0.27 | −0.41 |
| GA | 2.7 | 2.23 | −5.36 | 0.3 | 0.07 | −1.73 | 0.09 |
| GL | 2.6 | 2.23 | −5.36 | 0.3 | −4.19 | −1.03 | −0.98 |
| AG | 2.6 | 0.07 | −1.73 | 0.09 | 2.23 | −5.36 | 0.3 |
| GH | 2.51 | 2.23 | −5.36 | 0.3 | 2.41 | 1.74 | 1.11 |
| KG | 2.49 | 2.84 | 1.41 | −3.14 | 2.23 | −5.36 | 0.3 |
| FG | 2.43 | −4.92 | 1.3 | 0.45 | 2.23 | −5.36 | 0.3 |
| GS | 2.42 | 2.23 | −5.36 | 0.3 | 1.96 | −1.63 | 0.57 |
| GV | 2.34 | 2.23 | −5.36 | 0.3 | −2.69 | −2.53 | −1.29 |
| MG | 2.32 | −2.49 | −0.27 | −0.41 | 2.23 | −5.36 | 0.3 |
| GK | 2.27 | 2.23 | −5.36 | 0.3 | 2.84 | 1.41 | −3.14 |
| GE | 2.27 | 2.23 | −5.36 | 0.3 | 3.08 | 0.39 | −0.07 |
| GT | 2.24 | 2.23 | −5.36 | 0.3 | 0.92 | −2.09 | −1.4 |
| WG | 2.23 | −4.75 | 3.65 | 0.85 | 2.23 | −5.36 | 0.3 |
| HG | 2.2 | 2.41 | 1.74 | 1.11 | 2.23 | −5.36 | 0.3 |
| GQ | 2.15 | 2.23 | −5.36 | 0.3 | 2.18 | 0.53 | −1.14 |
| GG | 2.14 | 2.23 | −5.36 | 0.3 | 2.23 | −5.36 | 0.3 |
| QG | 2.13 | 2.18 | 0.53 | −1.14 | 2.23 | −5.36 | 0.3 |
| SG | 2.07 | 1.96 | −1.63 | 0.57 | 2.23 | −5.36 | 0.3 |
| LG | 2.06 | −4.19 | −1.03 | −0.98 | 2.23 | −5.36 | 0.3 |
| GD | 2.04 | 2.23 | −5.36 | 0.3 | 3.64 | 1.13 | 2.36 |
| TG | 2 | 0.92 | −2.09 | −1.4 | 2.23 | −5.36 | 0.3 |
| EG | 2 | 3.08 | 0.39 | −0.07 | 2.23 | −5.36 | 0.3 |
| PG | 1.77 | −1.22 | 0.88 | 2.23 | 2.23 | −5.36 | 0.3 |
| LA | 3.51 | −4.19 | −1.03 | −0.98 | 0.07 | −1.73 | 0.09 |
| KA | 3.42 | 2.84 | 1.41 | −3.14 | 0.07 | −1.73 | 0.09 |
| RA | 3.34 | 2.88 | 2.52 | −3.44 | 0.07 | −1.73 | 0.09 |
| YA | 3.34 | −1.39 | 2.32 | 0.01 | 0.07 | −1.73 | 0.09 |
| FR | 3.04 | −4.92 | 1.3 | 0.45 | 2.88 | 2.52 | −3.44 |
| HL | 2.49 | 2.41 | 1.74 | 1.11 | −4.19 | −1.03 | −0.98 |
| DA | 2.42 | 3.64 | 1.13 | 2.36 | 0.07 | −1.73 | 0.09 |
| EA | 2 | 3.08 | 0.39 | −0.07 | 0.07 | −1.73 | 0.09 |
| DM | 2.7782 | 3.64 | 1.13 | 2.36 | −2.49 | −0.27 | −0.41 |
| IP | 3.89 | 2.92 | −4.44 | −1.68 | −1.22 | 0.88 | 2.23 |
*Z the first number (m) behind Z represents the sequence of the amino acid in peptide, and the second number (n, from 1 to 3) represents the hydrophilic amino acids, three-dimensional shape, size, and electrical parameters, respectively.
Figure 1Diagram of BP-ANN model of ACE-inhibitory peptides' QSAR.
Reagents used in determination of ACE inhibiting activity.
| Blank ( | Sample ( | |
|---|---|---|
| ACE (0.1 U/mL) | 10 | 10 |
| FAPGG (1 mmol/L)1 | 50 | 50 |
| HEPES buffer2 | 40 | 0 |
| Sample | 0 | 40 |
1FAPGG (1.0 mmol/L): prepared with 0.08 M HEPES buffer (pH 8.3) containing 0.3 M NaCl.
2HEPES buffer: HEPES 1.910 g, NaCl 1.755 g, dissolved with double-distilled water, pH adjusted with NaOH, and metered volume with double-distilled water to 100 mL, stored at 4°C.
Figure 2The correlation coefficient R values varied with the numbers of hidden layer neurons.
Figure 3The predicting results of the (6-7-1) BP network model on the set of prediction.
Figure 4The parametric diagram of BP network model.
The neurons weights from input layer to hidden layer.
| Neurons |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| (1) | −0.3515 | 0.28331 | 0.28286 | −0.44043 | 0.037431 | −0.085447 |
| (2) | 0.27249 | 0.041643 | −0.9822 | −0.087255 | 0.47412 | −0.18318 |
| (3) | 0.57416 | −0.14092 | 0.60775 | −0.08924 | 0.11108 | −0.5922 |
| (4) | 0.24392 | 0.21597 | −0.20115 | 0.24221 | −0.07429 | −0.54316 |
| (5) | 0.23817 | 0.07212 | 0.68217 | −0.00285 | 0.26846 | −0.47522 |
| (6) | −0.30588 | 0.21639 | 0.036361 | −0.41676† | −0.2514‡ | −0.23479 |
| (7) | −0.090315 | −0.058403 | 0.0745 | −0.32458† | −0.24483‡ | −0.10795 |
*Z the first number (m) behind Z represents the sequence of the amino acid in peptide, and the second number (from 1 to 3) represents the hydrophilicity of amino acids, three-dimensional shape, size, and electrical parameters, respectively.
Amino acid composition of wheat germ protein isolates (g/100 g protein).
| Amino acid | Content |
|---|---|
| Asp +Asn | 8.40 |
| Glu + Gln | 15.28 |
| Ser | 4.40 |
| His | 3.15 |
| Gly | 6.19 |
| Thr | 3.94 |
| Arg | 9.79 |
| Ala | 6.41 |
| Tyr | 2.97 |
| Cys | 0.39 |
| Val | 7.20 |
| Met | 1.70 |
| Phe | 5.22 |
| Ile | 4.94 |
| Leu | 8.07 |
| Lys | 6.33 |
| Pro | 5.63 |
| Trp | 0.69 |
| Hydrophobic amino acids | 42.84 |
| Aromatic amino acids | 8.89 |
Figure 5The degree of hydrolysis of DWGP hydrolysate treated with Alcalase and Neutrase.
Figure 6The ACE-inhibitory activity of DWGP hydrolysate treated with Alcalase and Neutrase.